Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
Role in the project
Biogen supports a progressive regulatory framework and views regulatory sandboxes as an important potential tool that may help to accommodate the regulatory assessment of future innovation. Biogen is actively participating in several areas of the IHI project, with particular focus on developing the coalition of sandbox implementers and the integration of the sandbox into the EU regulatory framework.